|
Applicant Name
|
Project Name
|
Grants Awarded for 2009
|
Grants Awarded for 2010
|
Location
|
|
Aastrom Biosciences, Inc.
|
A Phase III Stage Expanded, Autologous Stem Cell Product to Treat Severe CV Disease
|
$244,479.24
|
|
Ann Arbor Township
|
|
Accord Biomaterials Inc
|
Improved central venous and hemodialysis catheters to minimize infection and clotting
|
$211,615.81
|
$32,863.44
|
Ann Arbor
|
|
Accord Biomaterials, Inc.
|
Coronary stent with passivated surfaces to address restenosis and late-stage thrombosis
|
$178,815.24
|
$65,664.01
|
Ann Arbor
|
|
Accord Biomaterials, Inc.
|
Point-of-Care Diagnostic and Therapy Management Tool for Pulmonary Arterial Hypertension
|
$20,493.75
|
$189,918.09
|
Ann Arbor
|
|
Accuri Cytometers Inc
|
Development of the Accuri CS Clinical Flow Cytometry System
|
$244,479.25
|
|
Pittsfield
|
|
Adeona Pharmaceuticals, Inc.
|
Estriol (Trimesta)
|
$35,493.50
|
$208,985.75
|
Ann Arbor
|
|
Adeona Pharmaceuticals, Inc.
|
Zinthionein and ZincMonoCysteine
|
$133,439.00
|
$111,040.25
|
Ann Arbor
|
|
AlphaCore Pharma, LLC
|
Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion
|
$244,479.25
|
|
Scio Twp
|
|
Cardiavent Inc.
|
Development of CARD-024 for the treatment of hypertension and heart failure
|
$66,868.50
|
$177,610.75
|
Ann Arbor
|
|
Cayman Chemical Company Inc
|
EP4 Project
|
|
$172,016.50
|
Pittsfield
|
|
Cayman Chemical Company Inc
|
H-PGDS Inhibition Project
|
$96,509.00
|
$31,848.00
|
Pittsfield
|
|
Cayman Chemical Company, Inc
|
Tetranor Prostaglandin E Metabolite ELISA Project
|
$11,769.00
|
$11,557.50
|
Pittsfield
|
|
Cerenis Therapeutics Inc
|
HDL-Mimetic Peptide/Phospholipid complex (CER-522)
|
$165,319.49
|
$79,159.76
|
Ann Arbor
|
|
Cerenis Therapeutics Inc.
|
CER-627 Low Flushing Niacin
|
$117,626.86
|
$63,100.93
|
Ann Arbor
|
|
Cerenis Therapeutics, Inc.
|
CER-002
|
$43,428.26
|
$125,479.14
|
Ann Arbor
|
|
Compendia Bioscience, Inc.
|
Oncopredictor
|
$122,116.50
|
$122,362.74
|
Ann Arbor
|
|
CytoPherx, Inc
|
Selective CytoPheretic Device
|
$244,479.25
|
|
Pittsfield
|
|
Delphinus Medical Technologies, inc.
|
Commercialization of SoftVue for early detection of Breast cancer
|
$238,705.00
|
$5,774.25
|
MLISC
|
|
Esperion Therapeutics, Inc
|
ETC-1002
|
$244,479.24
|
|
MLISC
|
|
Genetics Squared, Inc.
|
Commercialization of a Stage I and II colorectal Cancer Recurrence Prognostic Technology
|
$244,479.24
|
|
Pittsfield
|
|
Hygieia Inc
|
PRIVATE-DOC
|
$80,761.72
|
$163,717.53
|
Ann Arbor
|
|
Innovative BioTherapies, Inc
|
Bioengineered Cellular/ Biomimetic-based Therapeutic System for treatment of SIRS
|
$244,479.24
|
|
Pittsfield
|
|
Integrated Sensing Systems
|
Wireless Pressure Monitoring Implant for Tailored Medication of Cardiovascular Diseases
|
$244,479.24
|
|
Ypsilanti Township
|
|
Integrated Sensing Systems
|
A Microfluidic-Based Therapeutic Drug Infusion System
|
$244,479.25
|
|
Ypsilanti Township
|
|
Life Magnetics, Inc
|
Sensitive, Rapid Diagnostic device for Antibiotic Susceptibility Testing
|
|
$193,692.00
|
Ann Arbor
|
|
Lycera Corp
|
ATPase Oral Therapeutic
|
$244,479.24
|
|
MLISC
|
|
Lycera Corp.
|
RoR Gamma Therapeutic
|
$244,479.24
|
|
MLISC
|
|
Meditrina Pharmaceuticals Inc.
|
MPI-676
|
$12,860.00
|
$231,619.24
|
Ann Arbor
|
|
Michigan Critical Care Consultants Inc DBA MC3 Inc
|
Hyperthermia device for cancer treatment
|
$36,179.85
|
$98,601.27
|
Scio Twp
|
|
Michigan Critical Care Consultants Inc DBA MC3 Inc
|
Catheter Enterogenesis Device Development
|
|
$40,746.68
|
Scio Twp
|
|
Michigan Critical Care Consultants, Inc. DBA MC3, Inc.
|
Pediatric blood pump development
|
$93,822.77
|
$150,656.47
|
Scio Twp
|
|
Michigan Critical Care Consultants, Inc. DBA MC3, Inc.
|
Artificial Lung Development
|
$93,587.07
|
$150,892.17
|
Scio Twp
|
|
Michigan Critical Care Consultants, Inc., DBA MC3, Inc.
|
Bidirectional Arterial Cannula Development
|
$80,991.20
|
$163,488.04
|
Scio Twp
|
|
Michigan Critical Care Consultants, Inc., DBA MC3, Inc.
|
Annuloplasty Ring for Heart Valve Disease
|
$17,393.01
|
$46,276.11
|
Scio Twp
|
|
Michigan Critical Care Consultants, Inc., DBA MC3, Inc.
|
Automatic Perfusion System Development
|
$13,314.69
|
$70,696.82
|
Scio Twp
|
|
Michigan Critical Care Consultants, Inc., DBA MC3, Inc.
|
Simple Ventricular Assist Device Development
|
|
$53,422.38
|
Scio Twp
|
|
MICHIGAN TECHNOLOGY & RESEARCH INSTITUTE, LLC
|
GENETIC CHARACTERIZATION OF FIBROSIS & INFLAMMATORY SUSCEPTIBILITY IN CHRONIC KIDNEY DISEASE
|
$22,191.00
|
$29,406.00
|
Ann Arbor
|
|
NanoBio Corporation
|
Novel Nebulized Therapy for Cystic Fibrosis
|
$244,479.25
|
|
Ann Arbor
|
|
NanoBio Corporation
|
Novel Topical Therapy for Herpes Labialis
|
$244,479.25
|
|
Ann Arbor
|
|
NanoBio Corporation
|
Novel Intranasal Vaccine Adjuvant
|
$244,479.25
|
|
Ann Arbor
|
|
NanoBio Corporation
|
Novel Intranasal 23- Valent Pneumococcal Vaccine
|
$244,479.25
|
|
Ann Arbor
|
|
NanoBio Corporation
|
Novel Topical Anti-fungal Therapy for Tinea Capitis and Onychomycosis
|
$244,479.25
|
|
Ann Arbor
|
|
NeuroNexus Technologies, Inc.
|
Deep Brain Stimulation
|
$162,088.50
|
$47,855.50
|
Pittsfield
|
|
Novalung, Inc.
|
Development of pump for use with artificial lung
|
$226,495.16
|
$17,984.08
|
Ann Arbor
|
|
Nustep, Inc
|
Metabolic Cost of Recumbent Exercise in Overweight Individuals
|
|
$32,500.00
|
Pittsfield
|
|
Nymirum Inc
|
Alzheimer's Project
|
$17,248.00
|
$227,231.25
|
Scio Twp
|
|
Nymirum Inc
|
Hepatitis C Project
|
$9,764.50
|
$234,714.75
|
Scio Twp
|
|
Nymirum, Inc
|
Myotonic Dystrophy Project
|
$30,283.50
|
$214,195.75
|
Scio Twp
|
|
Phrixus Pharmaceuticals, Inc
|
Heart Failure
|
$168,430.00
|
$76,049.24
|
Ann Arbor
|
|
Phrixus Pharmaceuticals, Inc
|
Duchenne Muscular Dystrophy
|
$168,430.00
|
$76,049.24
|
Ann Arbor
|
|
QuatRx Pharmaceuticals Company
|
Ospemifene
|
$244,479.25
|
|
Ann Arbor
|
|
RetroSene Therapeutics LLC aka RetroSense Therapeutics LLC
|
Gene therapy for vision restoration
|
$1,750.00
|
$161,094.43
|
Ann Arbor
|
|
Rubicon Genomics, Inc
|
Development of PicoPlex -NGS Kits
|
$85,674.50
|
$99,166.50
|
Ann Arbor
|
|
Rubicon Genomics, Inc.
|
Development of MethylPlex ™ -NGS Kits
|
$80,501.00
|
$129,187.00
|
Ann Arbor
|
|
Sonetics Ultrasound, Inc.
|
Fully-sampled 2D/planar ultrasound transducer technology
|
$185,276.47
|
$59,202.78
|
Pittsfield
|
|
Swift Biosciences Inc
|
Development of High Sensitivity Genetic Tests for Detection and Assessment of Cancer
|
|
$244,479.24
|
Scio Twp
|
|
Tangent Medical Technologies
|
Peripheral intravenous therapeutic delivery device
|
|
$244,479.25
|
Ann Arbor
|
|
TCH Pharmaceuticals, Inc
|
Imidazoline-based Inhibitors
|
$17,519.50
|
$40,082.00
|
Ann Arbor
|
|
Therapeutic System Research Laboratories, Inc. (TSRL)
|
Anti-Influenza Therapeutic
|
$53,603.56
|
$43,987.62
|
Pittsfield
|
|
Therapeutic Systems Research Laboratories, Inc (TSRL)
|
Cidofovir, Nucleoside Prodrug for Antiviral Treatment
|
$244,479.25
|
|
Pittsfield
|
|
Therapeutic Systems Research Laboratories, Inc. (TSRL)
|
Bile Acid Carrier
|
$85,919.29
|
$24,184.42
|
Pittsfield
|
|
Therapeutic Systems Research Laboratories, Inc. (TSRL)
|
Inflammatory Bowel Disease Therapeutic
|
$45,127.53
|
$75,793.37
|
Pittsfield
|
|
Ultrasound Medical Devices Inc
|
imaging of cardiovascular mechanical function for assessment diagnosis and therapy guidance
|
$221,258.00
|
$23,221.25
|
Ann Arbor
|
|
Velcura Therapeutics, Inc.
|
VEL-0230 an Orally Available, Disease Modifying Anti-Rheumatic Drug (DMARD)
|
$194,016.10
|
|
Ann Arbor
|
|
Xoran Technologies Inc
|
Xoran xCAT
|
$244,479.25
|
|
Pittsfield
|
|
Xoran Technologies, Inc.
|
Xoran MiniCAT
|
$244,479.25
|
|
|
|
|
|
$8,536,271.76
|
$4,862,053.49
|
|